Skip to main content
Premium Trial:

Request an Annual Quote

Wako Distributing Cellectis Products in Japan

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – French genomic engineering firm Cellectis said on Wednesday it has appointed Wako Pure Chemical Industries as its exclusive distributor in Japan.

Wako will handle sales of Cellectis' products including its Talen Access service, launched in February. In a statement, Luc Selig, vice president of sales and marketing for Cellectis, said that the company is targeting global distribution of Talen, which is a tool for specifically modifying genes in any type of cell.

Calling Japan a "major player in life science research," he said that "Wako will allow us to enter this important market effectively."

Financial and other terms of the deal were not disclosed.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.